Ignite Creation Date:
2024-05-06 @ 12:16 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01534260
Status:
COMPLETED
Last Update Posted:
2018-08-17
First Post:
2012-02-13
Brief Title:
Phase III Study of Combination of Sorafenib Vorinostat and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk Monosomy 57 Cytogenetics or FLT3-ITD Positive Genotype
Sponsor:
Organization:
Indiana University